Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Asma Abdul Majid"'
Autor:
Mohamed Hammad, Yvonne R. Cornejo, Jennifer Batalla-Covello, Asma Abdul Majid, Connor Burke, Zheng Liu, Yate-Ching Yuan, Min Li, Thanh H. Dellinger, Jianming Lu, Nanhai G. Chen, Yuman Fong, Karen S. Aboody, Rachael Mooney
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss , Pp 326-334 (2020)
Oncolytic virotherapy represents a promising approach for treating recurrent and/or drug-resistant ovarian cancer. However, its successful application in the clinic has been hampered by rapid immune-mediated clearance, which reduces viral delivery to
Externí odkaz:
https://doaj.org/article/a51f6d5caa604ac6b003ff4ce600670f
Autor:
Rachael Mooney, Asma Abdul Majid, Jennifer Batalla-Covello, Diana Machado, Xueli Liu, Joanna Gonzaga, Revathiswari Tirughana, Mohamed Hammad, Maciej S. Lesniak, David T. Curiel, Karen S. Aboody
Publikováno v:
Molecular Therapy: Oncolytics, Vol 12, Iss , Pp 79-92 (2019)
Oncolytic virotherapy is a promising approach for treating recurrent and/or drug-resistant ovarian cancer. However, its successful application in the clinic has been hampered by rapid immune-mediated clearance or neutralization of the virus, which re
Externí odkaz:
https://doaj.org/article/640fdbac5c2342d1857ec93f5bfc628b
Autor:
Rachael Mooney, Asma Abdul Majid, Jennifer Batalla-Covello, Diana Machado, Xueli Liu, Joanna Gonzaga, Revathiswari Tirughana, Mohamed Hammad, Thanh H. Dellinger, Maciej S. Lesniak, David T. Curiel, Karen S. Aboody
Publikováno v:
Molecular Therapy: Oncolytics, Vol 17, Iss , Pp 508- (2020)
Externí odkaz:
https://doaj.org/article/808f783cf0f84bda91871996e2c3146f
Autor:
Rachael Mooney, Asma Abdul Majid, Daniel Mota, Adam He, Soraya Aramburo, Linda Flores, Jennifer Covello-Batalla, Diana Machado, Joanna Gonzaga, Karen S. Aboody
Publikováno v:
Stem Cells International, Vol 2018 (2018)
Tumor-tropic neural stem cells (NSCs) can be engineered to localize gene therapies to invasive brain tumors. However, like other stem cell-based therapies, survival of therapeutic NSCs after transplantation is currently suboptimal. One approach to pr
Externí odkaz:
https://doaj.org/article/dd1bd1411a5148d684d28764d22dc201
Autor:
Rachael Mooney, Wafa Abidi, Jennifer Batalla-Covello, Hoi Wa Ngai, Caitlyn Hyde, Diana Machado, Asma Abdul-Majid, Yanan Kang, Mohamed Hammad, Linda Flores, Greg Copeland, Thanh Dellinger, Ernest Han, Jacob Berlin, Karen S. Aboody
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-11 (2021)
Abstract Background Immortalized, clonal HB1.F3.CD 21 human neural stem/progenitor cells (NSCs), loaded with therapeutic cargo prior to intraperitoneal (IP) injection, have been shown to improve the delivery and efficacy of therapeutic agents in pre-
Externí odkaz:
https://doaj.org/article/00aec8cde6834fa89e6974502295b6ea
Autor:
Zheng Liu, Karen S. Aboody, Connor Burke, Min Li, Yuman Fong, Jianming Lu, Yate-Ching Yuan, Rachael Mooney, Jennifer Batalla-Covello, Yvonne R. Cornejo, Asma Abdul Majid, Mohamed Hammad, Thanh H. Dellinger, Nanhai G. Chen
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss, Pp 326-334 (2020)
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics
Oncolytic virotherapy represents a promising approach for treating recurrent and/or drug-resistant ovarian cancer. However, its successful application in the clinic has been hampered by rapid immune-mediated clearance, which reduces viral delivery to
Autor:
Jennifer Batalla-Covello, Wafa Abidi, Hoi Wa Ngai, Caitlyn Hyde, Diana Machado, Asma Abdul Majid, Mohamed Hammad, Linda Flores, Gregory Copeland, Thanh Dellinger, Ernest Han, Jacob Berlin, Karen Aboody, Rachael Mooney
Background: Immortalized, clonal HB1.F3.CD21 human neural stem/progenitor cells (NSCs), loaded with therapeutic cargo prior to intraperitoneal (IP) injection, have been shown to improve the delivery and efficacy of therapeutic agents in pre-clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3e1e2038452d58b9e8da9d78b8ccbf1
https://doi.org/10.21203/rs.3.rs-57439/v1
https://doi.org/10.21203/rs.3.rs-57439/v1
Publikováno v:
Stem Cells Translational Medicine
Cancer is one of the leading causes of morbidity and mortality worldwide, with 1,688,780 new cancer cases and 600,920 cancer deaths projected to occur in 2017 in the U.S. alone. Conventional cancer treatments including surgical, chemo-, and radiation
Autor:
Jennifer Covello-Batalla, Daniel J. Mota, Linda Flores, Adam He, Soraya Aramburo, Joanna Gonzaga, Diana Machado, Rachael Mooney, Asma Abdul Majid, Karen S. Aboody
Publikováno v:
Stem Cells International
Stem Cells International, Vol 2018 (2018)
Stem Cells International, Vol 2018 (2018)
Tumor-tropic neural stem cells (NSCs) can be engineered to localize gene therapies to invasive brain tumors. However, like other stem cell-based therapies, survival of therapeutic NSCs after transplantation is currently suboptimal. One approach to pr
Autor:
Joanna Gonzaga, David T. Curiel, Jennifer Batalla-Covello, Karen S. Aboody, Asma Abdul Majid, Mohamed Hammad, Rachael Mooney, Maciej S. Lesniak, Revathiswari Tirughana, Xueli Liu, Thanh H. Dellinger, Diana Machado
Publikováno v:
Molecular Therapy: Oncolytics, Vol 12, Iss, Pp 79-92 (2019)
Molecular Therapy: Oncolytics, Vol 17, Iss, Pp 508-(2020)
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 17, Iss, Pp 508-(2020)
Molecular Therapy Oncolytics
Oncolytic virotherapy is a promising approach for treating recurrent and/or drug-resistant ovarian cancer. However, its successful application in the clinic has been hampered by rapid immune-mediated clearance or neutralization of the virus, which re